News

FDA names former pharmaceutical company executive to oversee US drug program
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
FDA appoints George Tidmarsh as top drug regulator
By Sriparna Roy and Sneha S K (Reuters) -The U.S. Food and Drug Administration said on Monday it has appointed George ...
FDA to appoint George Tidmarsh as top drug regulator, Bloomberg News reports
U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the ...
FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
Sarepta stock extends decline as company declines FDA call to withdraw drug
Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and ...
InvestorsHub on MSN1h
ProMIS Neurosciences stock price surges in pre market trading as company receives FDA fast track designation for alzheimer’s drug candidate PMN310
ProMIS Neurosciences Inc. (Nasdaq:PMN), a clinical-stage biotechnology firm specializing in treatments for neurodegenerative ...
STAT1h
FDA taps biotech veteran George Tidmarsh to lead drug center
The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...
Infectious Disease Advisor22m
FDA Plans to Revoke 52 Food Standards
The US Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they are "obsolete and unnecessary." ...
MEAT+POULTRY19m
FDA looks into standards of identity for various food categories
The US Food and Drug Administration aims to revoke 52 standards of identity (SOI) across a swath of food categories, claiming the regulations are “obsolete and unnecessary.” Under the proposal, ...
C-SPAN17m
Video Clip: FDA Commissioner Makary on Agency Actions and Goals
Food and Drug Administration (FDA) Commissioner Dr. Marty Makary talked about the actions the agency has taken during his first 100 days in office and related goals during his tenure.
Health Cuts Would Result in Fewer Drugs for Americans, Budget Office Reports
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
FDA approves new blue food dye derived from gardenia fruit
The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering ...